Conditions: Schizophrenia
Keywords: Safety Tolerability Schizophrenia Aripiprazole
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 60
Healthy volunteers: no

Brief summary:
This study will test the safety of an aripiprazole injection in subjects with schizophrenia that are currently taking oral antipsychotic medication other than aripiprazole. Subjects in this study will receive one injection of aripiprazole and will need to stop taking their other antipsychotic medication two weeks after the injection. The study will last one month. Subjects will be required to come to a clinic for evaluations and drug and urine collection five times during the course of the study.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Aripiprazole IM Depot
Intervention descriptions: intervention 1: 400 mg intramuscular injection of aripiprazole

Protocol document: